Leading Science. Changing Lives.

Over the past five years, cancer research has outpaced our wildest imagination. By giving to MSK, you’re advancing our mission of ending cancer for life.
MSK researchers in a lab.

Read the '2025 MSK Annual Report: Progress Made Personal'

View the full report
Dr. Selwyn M. Vickers, President and CEO of MSK.

We are the most capable force against cancer the world has ever seen, and the MSK Giving community is an essential part of our strength.

–Selwyn M. Vickers, MD, FACS

We’re at a turning point

Your gift enables us to explore promising research the moment it emerges. That’s why, with your help, we plan to raise $6 billion by 2030.

The progress you’re already making possible

Since launching, The MSK Campaign has raised more than $4.5 billion, thanks to our inspiring and generous donor community. Here’s some of what you’ve helped make possible:
Lab coat with blue logo in busy laboratory setting.
1,726
Clinical trials
launched since 2019
50+
FDA approvals
based on MSK research
52
Fellowships
funded since 2019

 

Boundary-pushing initiatives 

Your support fuels MSK’s mission of ending cancer for life across these six strategic initiatives. 

 

 An MSK doctor speaks with a patient and caregiver.
 An MSK researcher in a lab holding a pipette over a test tube.
MSK researcher and oncologist Dr. Christopher Klebanoff.
MSK’s Dr. David Solit with researchers in a lab.
Dr. Sohrab Shah, Chief of Computational Oncology at MSK.
MSK’s Dr. Jason Lewis, a professor at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, with a trainee.
Ready to transform cancer care?
Make your impact
To discover more ways to partner in our work, email us.
Contact us